{"transactions":[{"id":727741,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T23:07:53.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":false,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests as to 25% on the one year anniversary of August 29, 2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":152250,"derivative":{"exercise_price":2.93,"expiration_date":"2032-08-28","underlying":"Class A Common Stock","underlying_shares":63000},"source":{"system":"sec-edgar","filing":"0001369453-26-000008","document":"form4-06242026_110649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000008/form4-06242026_110649.xml","form_type":"4"}},{"id":727740,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-24T23:07:53.000Z","date":"2026-06-23","kind":"sale","planned":true,"acquired":false,"shares":63000,"price":6.0189,"value":379190.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan dated December 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $6.00 to $6.08. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":53000,"source":{"system":"sec-edgar","filing":"0001369453-26-000008","document":"form4-06242026_110649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000008/form4-06242026_110649.xml","form_type":"4"}},{"id":727739,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-24T23:07:53.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":true,"shares":63000,"price":2.93,"value":184590.0,"ownership":{"direct":true},"balance_after":116000,"source":{"system":"sec-edgar","filing":"0001369453-26-000008","document":"form4-06242026_110649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000008/form4-06242026_110649.xml","form_type":"4"}},{"id":803764,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T20:35:16.000Z","date":"2026-04-17","kind":"exercise","planned":true,"acquired":false,"shares":36750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests as to 25% on the one year anniversary of August 29, 2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":215250,"derivative":{"exercise_price":2.93,"expiration_date":"2032-08-28","underlying":"Class A Common Stock","underlying_shares":36750},"source":{"system":"sec-edgar","filing":"0001369453-26-000006","document":"form4-04212026_080412.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000006/form4-04212026_080412.xml","form_type":"4"}},{"id":803763,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-04-21T20:35:16.000Z","date":"2026-04-17","kind":"sale","planned":true,"acquired":false,"shares":36750,"price":5.0144,"value":184279.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan dated December 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.05. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":53000,"source":{"system":"sec-edgar","filing":"0001369453-26-000006","document":"form4-04212026_080412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000006/form4-04212026_080412.xml","form_type":"4"}},{"id":803762,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-04-21T20:35:16.000Z","date":"2026-04-17","kind":"exercise","planned":true,"acquired":true,"shares":36750,"price":2.93,"value":107677.5,"ownership":{"direct":true},"balance_after":89750,"source":{"system":"sec-edgar","filing":"0001369453-26-000006","document":"form4-04212026_080412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000006/form4-04212026_080412.xml","form_type":"4"}},{"id":812607,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-08T20:23:17.000Z","date":"2026-04-06","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":1.94,"expiration_date":"2033-02-27","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001369453-26-000005","document":"form4-04082026_080413.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000005/form4-04082026_080413.xml","form_type":"4"}},{"id":812606,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-08T20:23:17.000Z","date":"2026-04-06","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":400000,"derivative":{"exercise_price":1.87,"expiration_date":"2034-02-27","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001369453-26-000005","document":"form4-04082026_080413.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000005/form4-04082026_080413.xml","form_type":"4"}},{"id":812605,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-04-08T20:23:17.000Z","date":"2026-04-06","kind":"sale","planned":true,"acquired":false,"shares":200000,"price":4.5178,"value":903560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan dated December 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $4.44 to $4.64. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":53000,"source":{"system":"sec-edgar","filing":"0001369453-26-000005","document":"form4-04082026_080413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000005/form4-04082026_080413.xml","form_type":"4"}},{"id":812604,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-04-08T20:23:17.000Z","date":"2026-04-06","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":1.94,"value":194000.0,"ownership":{"direct":true},"balance_after":253000,"source":{"system":"sec-edgar","filing":"0001369453-26-000005","document":"form4-04082026_080413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000005/form4-04082026_080413.xml","form_type":"4"}},{"id":812603,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-04-08T20:23:17.000Z","date":"2026-04-06","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":1.87,"value":187000.0,"ownership":{"direct":true},"balance_after":153000,"source":{"system":"sec-edgar","filing":"0001369453-26-000005","document":"form4-04082026_080413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000005/form4-04082026_080413.xml","form_type":"4"}},{"id":867965,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T01:02:37.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":748130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":748130,"derivative":{"exercise_price":5.91,"expiration_date":"2036-02-26","underlying":"Class A Common Stock","underlying_shares":748130},"source":{"system":"sec-edgar","filing":"0001369453-26-000003","document":"form4-03042026_010334.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000003/form4-03042026_010334.xml","form_type":"4"}},{"id":1106405,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-06-18T20:05:10.000Z","date":"2025-06-16","kind":"purchase","planned":false,"acquired":true,"shares":24000,"price":1.8,"value":43200.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001415889-25-017657","document":"form4-06182025_040604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925017657/form4-06182025_040604.xml","form_type":"4"}},{"id":1106404,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-06-18T20:05:10.000Z","date":"2025-06-16","kind":"purchase","planned":false,"acquired":true,"shares":26000,"price":1.79,"value":46540.0,"ownership":{"direct":true},"balance_after":26000,"source":{"system":"sec-edgar","filing":"0001415889-25-017657","document":"form4-06182025_040604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925017657/form4-06182025_040604.xml","form_type":"4"}},{"id":1229185,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-04T23:37:21.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 2/28/2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":1.97,"expiration_date":"2035-02-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001415889-25-006705","document":"form4-03042025_110318.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925006705/form4-03042025_110318.xml","form_type":"4"}},{"id":1603437,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-04T22:25:49.000Z","date":"2024-02-29","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":1.87,"expiration_date":"2034-02-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001415889-24-006313","document":"form4-03042024_100333.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588924006313/form4-03042024_100333.xml","form_type":"4"}},{"id":1979868,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-02T22:57:51.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date"}],"balance_after":400000,"derivative":{"exercise_price":1.94,"expiration_date":"2033-02-27","underlying":"Class A Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001209191-23-014884","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919123014884/doc4.xml","form_type":"4"}},{"id":2170032,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-31T21:18:50.000Z","date":"2022-08-29","kind":"grant","acquired":true,"shares":252000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 8/29/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date"}],"balance_after":252000,"derivative":{"exercise_price":2.93,"expiration_date":"2032-08-28","underlying":"Class A Common Stock","underlying_shares":252000},"source":{"system":"sec-edgar","filing":"0001209191-22-048156","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919122048156/doc4.xml","form_type":"4"}},{"id":2256878,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-25T20:36:44.000Z","date":"2022-05-23","kind":"grant","acquired":true,"shares":247500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the Options will vest based on the satisfaction of both time-based and performance-based vesting criteria."}],"balance_after":247500,"derivative":{"exercise_price":3.78,"expiration_date":"2032-05-22","underlying":"Common Stock","underlying_shares":247500},"source":{"system":"sec-edgar","filing":"0001209191-22-031879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919122031879/doc4.xml","form_type":"4"}},{"id":2256877,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-25T20:36:44.000Z","date":"2022-05-23","kind":"grant","acquired":true,"shares":330000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 5/23/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":330000,"derivative":{"exercise_price":3.78,"expiration_date":"2032-05-22","underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001209191-22-031879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919122031879/doc4.xml","form_type":"4"}},{"id":2502576,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-19T10:04:54.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":11.41,"expiration_date":"2031-02-28","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-065709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065709/doc4.xml","form_type":"4"}},{"id":2502575,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-19T10:04:54.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":15500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":15.78,"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001209191-21-065709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065709/doc4.xml","form_type":"4"}},{"id":2502574,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-19T10:04:54.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":18000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":14.75,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-21-065709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065709/doc4.xml","form_type":"4"}},{"id":2502573,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-19T10:04:54.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":33333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":22.31,"expiration_date":"2028-01-31","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001209191-21-065709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065709/doc4.xml","form_type":"4"}},{"id":2502572,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-19T10:04:54.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":18.56,"expiration_date":"2026-12-19","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-21-065709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065709/doc4.xml","form_type":"4"}},{"id":2502571,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-19T10:04:54.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":18.2,"expiration_date":"2026-01-03","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-065709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065709/doc4.xml","form_type":"4"}},{"id":2502570,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-19T10:04:54.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":18.16,"expiration_date":"2025-11-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-065709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065709/doc4.xml","form_type":"4"}},{"id":2502569,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-19T10:04:54.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":22.91,"expiration_date":"2025-01-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-065709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065709/doc4.xml","form_type":"4"}},{"id":2502568,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-19T10:04:54.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":24000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the effective time of the Merger, each outstanding option with an exercise price equal to, or greater than, $9.12 was cancelled without any consideration payable (whether in the form of cash or any potential CVR Payments) in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":19.61,"expiration_date":"2024-11-02","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-21-065709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065709/doc4.xml","form_type":"4"}},{"id":2502567,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2021-11-19T10:04:54.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":6000,"price":8.5,"value":51000.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2021, by and among Flexion Therapeutics, Inc. (\"Issuer\"), Pacira BioSciences, Inc. and Oyster Acquisition Company Inc. (\"Purchaser\") (\"Merger Agreement\"), on November 19, 2021, Purchaser merged with and into Issuer, with Issuer continuing as the surviving corporation (\"Merger\"). At the effective time of the Merger, each share of Issuer's common stock was cancelled in exchange for (i) $8.50 per share in cash (\"Cash Amount\"), plus (ii) one non-transferable contractual contingent value right per share, which represent the right to receive one or more contingent payments of up to $8.00 per share in the aggregate, in cash, upon the achievement of specified milestones on or prior to December 31, 2030 (\"CVR Payments\"). Pursuant to the Merger Agreement, these shares were tendered and disposed of at the offer acceptance time in exchange for the right to receive (i) the Cash Amount, plus (ii) any CVR Payments."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-065709","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065709/doc4.xml","form_type":"4"}},{"id":2502566,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2021-11-19T10:04:54.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":140843,"price":8.5,"value":1197165.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2021, by and among Flexion Therapeutics, Inc. (\"Issuer\"), Pacira BioSciences, Inc. and Oyster Acquisition Company Inc. (\"Purchaser\") (\"Merger Agreement\"), on November 19, 2021, Purchaser merged with and into Issuer, with Issuer continuing as the surviving corporation (\"Merger\"). At the effective time of the Merger, each share of Issuer's common stock was cancelled in exchange for (i) $8.50 per share in cash (\"Cash Amount\"), plus (ii) one non-transferable contractual contingent value right per share, which represent the right to receive one or more contingent payments of up to $8.00 per share in the aggregate, in cash, upon the achievement of specified milestones on or prior to December 31, 2030 (\"CVR Payments\"). Pursuant to the Merger Agreement, these shares were tendered and disposed of at the offer acceptance time in exchange for the right to receive (i) the Cash Amount, plus (ii) any CVR Payments."},{"field":"shares","element":"transactionShares","label":"F2","text":"At the effective time of the Merger, each outstanding restricted stock unit award (\"RSU\") was accelerated and became fully vested and was cancelled and converted into the right to receive (i) $8.50 per share of Issuer common stock issuable in settlement of such RSU in cash, net of any withholding taxes required to be deducted and withheld by applicable law, plus (ii) any potential CVR Payments."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes 481 shares of Issuer common stock acquired under the Issuer's 2013 Employee Stock Purchase Plan on November 17, 2021"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-065709","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121065709/doc4.xml","form_type":"4"}},{"id":2629160,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2021-07-20T20:49:54.000Z","date":"2021-07-19","kind":"sale","acquired":false,"shares":3944,"price":6.45,"value":25438.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares of common stock to cover tax withholding obligations associated with the vesting of restricted stock unit award granted to the Reporting Person on July 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $6.45. The shares were sold at a range of prices between $6.29 and $6.46.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":140362,"source":{"system":"sec-edgar","filing":"0001209191-21-047504","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121047504/doc4.xml","form_type":"4"}},{"id":2653282,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2021-06-28T18:09:25.000Z","date":"2021-06-21","kind":"grant","acquired":true,"shares":539,"price":7.78,"value":4193.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 539 shares by the Reporting Person on June 21, 2021, pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":144306,"source":{"system":"sec-edgar","filing":"0001209191-21-043523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121043523/doc4.xml","form_type":"4"}},{"id":2812638,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-03-03T18:35:50.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares shall vest on the one-year anniversary of January 1, 2021 (the \"Vesting Commencement Date\"), and thereafter 1/48th of the total shares shall vest each month following the one-year anniversary of the Vesting Commencement Date, so that all of the shares shall be vested four years after the Vesting Commencement Date."}],"balance_after":20000,"derivative":{"exercise_price":11.41,"expiration_date":"2031-02-28","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-017271","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121017271/doc4.xml","form_type":"4"}},{"id":2812637,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2021-03-03T18:35:50.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan."}],"balance_after":143767,"source":{"system":"sec-edgar","filing":"0001209191-21-017271","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121017271/doc4.xml","form_type":"4"}},{"id":2913592,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2021-01-07T17:56:57.000Z","date":"2021-01-05","kind":"sale","acquired":false,"shares":6829,"price":11.13,"value":76006.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares of common stock to cover tax withholding obligations associated with the vesting of restricted stock unit awards granted to the Reporting Person on February 1, 2018, March 1, 2019, and March 2, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $11.13. The shares were sold at a range of prices between $11.12 and $11.57.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 416 shares of common stock that were acquired by the Reporting Person on December 20, 2020, at $9.77 per share pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":113767,"source":{"system":"sec-edgar","filing":"0001209191-21-002565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919121002565/doc4.xml","form_type":"4"}},{"id":3079495,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2020-07-20T21:23:08.000Z","date":"2020-07-16","kind":"grant","acquired":true,"shares":38750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan. 1/3 of the shares subject to the restricted stock unit award vest on each of July 16, 2021, July 16, 2022 and July 16, 2023."}],"balance_after":120180,"source":{"system":"sec-edgar","filing":"0001209191-20-043107","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919120043107/doc4.xml","form_type":"4"}},{"id":3100782,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2020-06-24T16:09:34.000Z","date":"2020-06-22","kind":"grant","acquired":true,"shares":369,"price":10.83,"value":3996.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 369 shares by the Reporting Person on June 22, 2020 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":81430,"source":{"system":"sec-edgar","filing":"0001209191-20-038719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919120038719/doc4.xml","form_type":"4"}},{"id":3231965,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-03-03T16:18:11.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the shares shall vest on the one year anniversary of January 1, 2020 (the \"Vesting Commencement Date\") and thereafter one-forty-eighth (1/48th) of the total shares shall vest each month following the one year anniversary of the Vesting Commencement Date, so that all of the shares shall be vested four (4) years after the Vesting Commencement Date."}],"balance_after":15500,"derivative":{"exercise_price":15.78,"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001209191-20-015140","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919120015140/doc4.xml","form_type":"4"}},{"id":3231964,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2020-03-03T16:18:11.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan."}],"balance_after":81061,"source":{"system":"sec-edgar","filing":"0001209191-20-015140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919120015140/doc4.xml","form_type":"4"}},{"id":3316225,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2020-01-07T16:33:06.000Z","date":"2020-01-03","kind":"sale","acquired":false,"shares":3724,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares of common stock to cover tax withholding obligations associated with the vesting of restricted stock unit awards granted to the Reporting Person on February 1, 2018 and March 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at a range of prices between $19.73 and $19.88.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 391 shares of common stock that were acquired by the Reporting Person on December 20, 2019 at $9.89 per share pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":50061,"source":{"system":"sec-edgar","filing":"0001209191-20-002283","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919120002283/doc4.xml","form_type":"4"}},{"id":3395940,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Unit Award","published_at":"2019-10-08T16:27:35.000Z","date":"2019-10-06","kind":"exercise","acquired":false,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"3,400 shares subject to the restricted stock unit award vested as of October 6, 2019."}],"balance_after":0,"derivative":{"expiration_date":"2019-10-06","underlying":"Common Stock","underlying_shares":3400},"source":{"system":"sec-edgar","filing":"0001209191-19-052756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919119052756/doc4.xml","form_type":"4"}},{"id":3395939,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2019-10-08T16:27:35.000Z","date":"2019-10-07","kind":"tax_withholding","acquired":false,"shares":1002,"price":13.98,"value":14007.96,"ownership":{"direct":true},"balance_after":53394,"source":{"system":"sec-edgar","filing":"0001209191-19-052756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919119052756/doc4.xml","form_type":"4"}},{"id":3395938,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2019-10-08T16:27:35.000Z","date":"2019-10-06","kind":"exercise","acquired":true,"shares":3400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":54396,"source":{"system":"sec-edgar","filing":"0001209191-19-052756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919119052756/doc4.xml","form_type":"4"}},{"id":3479985,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2019-06-24T16:13:12.000Z","date":"2019-06-21","kind":"grant","acquired":true,"shares":389,"price":9.81,"value":3816.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 389 shares by the Reporting Person on June 21, 2019 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":50996,"source":{"system":"sec-edgar","filing":"0001209191-19-038761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919119038761/doc4.xml","form_type":"4"}},{"id":3611904,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Unit Award","published_at":"2019-03-05T20:17:20.000Z","date":"2018-10-06","kind":"exercise","acquired":false,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit award represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"3,400 shares subject to the restricted stock unit award vested as of October 6, 2018 and the remaining 3,400 shares vest as of October 6, 2019."}],"balance_after":3400,"derivative":{"expiration_date":"2019-10-06","underlying":"Common Stock","underlying_shares":3400},"source":{"system":"sec-edgar","filing":"0001209191-19-017155","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919119017155/doc4a.xml","form_type":"4/A","original_submission_date":"2018-10-09"}},{"id":3611903,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2019-03-05T20:17:20.000Z","date":"2018-10-08","kind":"tax_withholding","acquired":false,"shares":1002,"price":18.6,"value":18637.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of the restricted stock unit award."}],"balance_after":14876,"source":{"system":"sec-edgar","filing":"0001209191-19-017155","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919119017155/doc4a.xml","form_type":"4/A","original_submission_date":"2018-10-09"}},{"id":3611902,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2019-03-05T20:17:20.000Z","date":"2018-10-06","kind":"exercise","acquired":true,"shares":3400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit award represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":15878,"source":{"system":"sec-edgar","filing":"0001209191-19-017155","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919119017155/doc4a.xml","form_type":"4/A","original_submission_date":"2018-10-09"}},{"id":3611882,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock option (right to buy)","published_at":"2019-03-05T18:18:09.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest one year after January 1, 2019 (the \"Vesting Commencement Date\") and thereafter one-forty-eighth (1/48th) of the  total shares shall vest each month following the one year anniversary of the Vesting Commencement Date, so that all of the shares shall be vested four (4) years after the Vesting Commencement Date."}],"balance_after":18000,"derivative":{"exercise_price":14.75,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-19-016930","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919119016930/doc4.xml","form_type":"4"}},{"id":3611881,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2019-03-05T18:18:09.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50607,"source":{"system":"sec-edgar","filing":"0001209191-19-016930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919119016930/doc4.xml","form_type":"4"}},{"id":3703808,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2019-01-04T17:10:53.000Z","date":"2019-01-03","kind":"sale","acquired":false,"shares":622,"price":12.36,"value":7687.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares of common stock pursuant to Rule 10b5-1 arrangements to cover tax withholding obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on February 1, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 353 shares of common stock that were acquired by the Reporting Person on December 20, 2018 at $10.48 per share pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":11207,"source":{"system":"sec-edgar","filing":"0001209191-19-002084","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919119002084/doc4.xml","form_type":"4"}},{"id":3794279,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2018-10-09T16:30:50.000Z","date":"2018-10-08","kind":"tax_withholding","acquired":false,"shares":1002,"price":18.6,"value":18637.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on February 1, 2018."}],"balance_after":11476,"source":{"system":"sec-edgar","filing":"0001209191-18-054524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919118054524/doc4.xml","form_type":"4"}},{"id":3884936,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2018-06-22T16:37:09.000Z","date":"2018-06-20","kind":"other","acquired":true,"shares":171,"price":21.22,"value":3628.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 171 shares by the Reporting Person on June 20, 2018 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":12478,"source":{"system":"sec-edgar","filing":"0001209191-18-039232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919118039232/doc4.xml","form_type":"4"}},{"id":4079048,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-02-02T16:48:43.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest one year after January 1, 2018; thereafter one-forty-eighth (1/48th) of the shares subject to the option shall vest each month following the one year anniversary of January 1, 2018, so that all of the shares subject to the option shall be vested four (4) years after January 1, 2018."}],"balance_after":33333,"derivative":{"exercise_price":22.31,"expiration_date":"2028-01-31","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001209191-18-006934","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919118006934/doc4.xml","form_type":"4"}},{"id":4079047,"issuer":{"id":16545,"kind":"organization","name":"Flexion Therapeutics Inc","symbol":"FLXN"},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2018-02-02T16:48:43.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12307,"source":{"system":"sec-edgar","filing":"0001209191-18-006934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419600/000120919118006934/doc4.xml","form_type":"4"}}]}